Kreos Capital is Europe’s largest and leading provider of specialty finance to growth companies from early- to late-stage. Since 1998, as the first provider of this kind of financing dedicated to early- to late-stage companies across Europe and Israel, Kreos has adapted the experience of the US model to the European market. Having completed over 250 transactions and committing over $1 billion in 15 countries across Europe and in Israel, Kreos has a proven track record of helping portfolio companies grow throughout their business cycle whilst supporting the objectives of both the portfolio company and their equity sponsors.
Kreos is a value added partner, able to offer additional capital and more flexibility with lower equity dilution. Kreos’s international team has extensive entrepreneurial, debt financing and equity investing experience, covering all local European markets from its locations in London, Tel Aviv and Stockholm.
|Cappella Medical Devices||10/10||Series D||€10.5M||5|
|Transmode Systems||2/06||Venture Round||$4.78M||1|